Skip to content

Self-management of Type 1 Diabetes Under Functional Insulin Therapy

Evaluation of Self-management of Patients With Type 1 Diabetes After Education to Functional Insulin Therapy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02272348
Acronym
EVAUTODIAB
Enrollment
13
Registered
2014-10-22
Start date
2015-02-10
Completion date
2020-09-10
Last updated
2021-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal-bolus Multiple-dily Insulin Injections, Insulin Pump (CSII), Type 1 Diabetes

Keywords

Therapeutic education, Functional insulin therapy

Brief summary

Therapeutic education of patients is a mandatory component of intensive insulin therapy of type 1 diabetes in order to reach optimal safety and efficacy. Used educational methods aim at facilitating patients' autonomy in their own management of diabetes. Therefore, self-management of patient with type 1 diabetes must be systematically assessed in order to evaluate the effectiveness of education programs .The main objective of this prospective controlled randomized monocentric study is to assess the impact of functional insulin therapy on the level of self-management of patients with type 1 diabetes via Confidence In Diabetes Self-care scale (CIDS) test.

Detailed description

170 patients with type 1 diabetes, volunteering for education to functional insulin therapy, will be recruited by the Department od Endocrinology, Diabetes, Nutrition of Montpellier University Hospital. After inclusion, the patients will be randomized in 2 groups: group 1 will be immediately trained to functional insulin therapy and group 2 will be trained at the end of the study. The patients will be met as outpatients 3 months after inclusion. The primary endpoint will be the global score for CIDS questionnaire. Secondary endpoints will include: HbA1c level at month 3, frequency of hypoglycemia from inclusion to month 3, scores for each of the 20 items of CIDS questionnaire. An ancillary study will assess: the acceptability of the new EAD questionnaire which specifically evaluates the self-management of diabetes, the concordance validity of EAD and CDIS questionnaires, the reproducibility test-retest, the internal consistency and the sensitivity to change of EAD questionnaire.

Interventions

OTHERTraining course to functional insulin therapy

Carbohydrate counting, carbohydrate/insulin ratio, sensitivity to insulin factor

OTHERUsual diabetes management.

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Type 1 diabetes from at least 1 year * Age from 18 to 70 (70 not included) * Basal-bolus multiple-dily insulin injections or insulin pump (CSII) * Informed consent * Affiliated or benefit from an insurance regimen

Exclusion criteria

* Type 2 diabetes * Unable to make mathematic calculation * Pregnancy, breast-feeding or absence of effective contraception * Psychiatric and/or cognitive status uncompatible with study * Eating disorders * Law protected person, vulnerable person

Design outcomes

Primary

MeasureTime frameDescription
To assess the impact of therapeutic education by functional insulin therapy in patients with type 1 diabetes on their ability to disease self-management.three months (from inclusion until end of study)CIDS questionnaire

Secondary

MeasureTime frameDescription
To assess the effect of education to functional insulin therapy on HbA1c levelthree months (from inclusion until end of study)HbA1c
To assess the effect of education to functional insulin therapy on hypoglycemia frequencythree months (from inclusion until end of study)Hypoglycemia occurrence
To assess the effect of education to functional insulinotherapy on the score of each of the 20 items of CIDS questioonairethree months (from inclusion until end of study)CIDS questionnaire sub scores
To assess the validity, the concordance and the sensitivity to change of EAD questionnaire (specific for self-management of diabetes) in comparison with CIDS testthree months (from inclusion until end of study)EAD questionnaire score

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026